A review on the advancement of polydopamine (PDA)-based nanomaterials for cancer treatment

Area of Science:

• Nanomedicine and Biomedical Engineering
• Materials Science in Oncology

Background:

• Cancer treatment research is critical due to high incidence and harsh side effects of chemotherapy.
• Nanotechnology, particularly polymeric nanoparticles, shows promise for improved cancer diagnostics and drug delivery.
• Polymeric nanoparticles enhance drug efficacy, stability, and reduce adverse effects.

Purpose of the Study:

• To review the latest developments in polydopamine (PDA)-based cancer treatment.
• To summarize key findings, limitations, and emerging therapeutic trends of PDA nanomaterials.
• To discuss the properties and preparation methods of PDA-based nanomaterials for therapeutic applications.

Main Methods:

• Literature review of recent advancements in polydopamine nanomaterials for cancer therapy.
• Analysis of physicochemical properties of PDA-based nanomaterials relevant to therapeutics.
• Synthesis and characterization of polymeric nanoparticle-based nanomedicines.

Main Results:

• Polydopamine (PDA) nanomaterials, being polymeric, are identified as promising agents in nanomedicine.
• PDA-based nanomedicines facilitate targeted drug delivery, tumor imaging, hyperthermia, and photodynamic therapy.
• Physicochemical properties of PDA nanomaterials enable significant modifications for effective cancer treatment.

Conclusions:

• Polydopamine nanomaterials represent a versatile and effective platform for various cancer treatment strategies.
• Further research into PDA-based nanomedicines is warranted to overcome current limitations and explore new therapeutic avenues.
• The unique properties of PDA nanomaterials offer innovative solutions for enhanced cancer therapy.